Morning Brief: Top minds gather for Yahoo Finance's All Markets Summit

Tuesday, November 13, 2018

Get the Morning Brief sent directly to your inbox every Monday to Friday by 6:30 a.m. ET. Subscribe

What to watch today

Yahoo Finance’s All Markets Summit: America’s Financial Future will be live from Washington, D.C. from 8:45 a.m. to 3:00 p.m. ET. An all-star guest lineup of the brightest minds in politics and finance will come together to break down the implications from the recent midterm elections.

Home Depot (HD) will kick off retail earnings this week with its quarterly earnings report before the bell. Weed company Tilray (TLRY) will report after the market close. Analysts polled by Bloomberg are expecting earnings of $2.26 per share on $26.24 billion of revenue for Home Depot and a loss of 11 cents per share on $10.11 million of revenue for Tilray.

Read more

Top news

REUTERS/Pascal Rossignol/File photo
REUTERS/Pascal Rossignol/File photo

Amazon reportedly picks NYC and Northern Virginia for its split HQ2: Amazon.com Inc. (AMZN) will on Tuesday announce it has selected New York and Northern Virginia for its second headquarters, a source told Reuters. [Reuters]

More on Amazon HQ2:
Why Long Island City makes sense for Amazon [Yahoo Finance]
Why Crystal City would be the right call for Amazon’s HQ2 [Yahoo Finance]

Liu and Mnuchin talk trade for the first time in months: U.S. Treasury Secretary Steven Mnuchin and Chinese Vice Premier Liu He have resumed talks on trade, and a potential Washington visit by Liu is being considered before the nations’ top leaders meet later this month. [Reuters]

Tariffs on car imports back in the spotlight: The Trump administration’s top trade officials are reportedly expected to discuss the possibility of imposing tariffs of up to 25% on imported cars and parts on Tuesday. The U.S. Commerce Department submitted draft recommendations to the White House on its investigation into whether to impose these tariffs, based on national security. [Yahoo Finance UK]

Record biotech IPO may be worth the $7B: The biggest biotech IPO on record is coming soon. Moderna Therapeutics, one of the most closely watched biotechs, filed a registration statement with the Securities and Exchange Commission last week to raise up to $500 million. Moderna is valued at about $7 billion based on its last fundraising. The offering is likely to take place before the end of the year. [The Wall Street Journal]

Goldman Sachs tumbles on 1MDB scandal and `fear of the unknown’: Goldman Sachs Group Inc.’s (GS) reputation is facing one of its biggest crises of the decade — and now its shares are, too. Since prosecutors implicated a trio of Goldman Sachs bankers in a multibillion-dollar Malaysian fraud early this month, investors have endured an almost daily drip of news on the firm’s ties to the scandal. [Bloomberg]

More from Yahoo Finance

Trump: ‘Presidential harassment’ is hurting the stock market

Investors had no tolerance for poor earnings in Q3

3 signs bears are poised to devour the stock market bulls

Ron Howard: I’m ‘very convinced’ we should go to Mars

The Morning Brief provides a quick rundown on what to watch in the markets, top news stories, and the best of Yahoo Finance Originals.